VCNX — Vaccinex Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $2.20m
- $2.78m
- $0.60m
Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard
Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds
Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease
Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
Brief: Vaccinex Inc Files Non-Timely 10-K With U.S. SEC
Brief: Vaccinex Announces $1.5 Mln Registered Direct Offering
Brief: Vaccinex Inc - On Feb 27 Scott E. Royer Notified Co Of His Decision To Retire As CFO
Brief: Vaccinex Announces Multiple New Agreements for Access to ActivMAb Antigen Virus Technology
Brief: Vaccinex, Inc. Announces Reverse Stock Split
Brief: Point72 Asset Management LP Reports 9.9% Passive Stake In Vaccinex As Of February 6 - SEC Filing
Brief: Nasdaq Grants Vaccinex Extension Until March 4, 2024 To Regain Compliance With Listing Rule
Brief: Vaccinex Reports Clinical Benefit In Interim Analyses
Brief: Vaccinex Reports Positive Effect Of Pepinemab Treatment On New Biomarker Of Brain Inflammation In Neurodegenerative Diseases
Brief: Vaccinex Got Letter From Nasdaq Listing Staff Stating That Co Has Not Regained Compliance With Minimum Bid Price Standard
Brief: Vaccinex Announces Pricing Of $9.6 Million Public Offering
Brief: Vaccinex, Inc. Announces Reverse Stock Split
Brief: Vaccinex Files For Shelf Of Up To 3.8 Mln Shares By Selling Stockholders
Brief: Vaccinex - On May 25 Received Letter From Nasdaq Notifying Co It No Longer Complies With Requirement Under Nasdaq Listing Rule 5550(B)(1)
Brief: Vaccinex Inc - Filed A Prospectus Supplement Under Which, Co May Offer And Sell, Shares Of Its Common Stock Of Up To $4.4 Million